BENJAMIN SAMSTEIN, MD

ANN ARBOR, MI

Research Active
Surgery NPI registered 20+ years 50 publications 2018 – 2026 NPI: 1164463733

Practice Location

1500 EAST MEDICAL CENTER DRIVE
ANN ARBOR, MI 48109-5334

Phone: (800) 333-9013

What does BENJAMIN SAMSTEIN research?

Dr. Samstein studies liver transplantation, paying special attention to patients suffering from liver cancer, and those facing complications from liver surgeries. He has investigated various aspects of both living donor and deceased donor transplants, examining patient survival rates, complications, and recovery protocols. His research includes developing tools to predict which patients may experience early graft failure, and he advocates for minimally invasive surgical techniques to enhance recovery and reduce complications for patients undergoing liver surgery.

Key findings

  • 85% two-year overall survival rate for 35 patients undergoing deceased donor liver transplantation for colorectal liver metastases.
  • The EAGLE-LDLT model accurately identified 40% of high-risk patients for early graft failure after living donor liver transplantation, using data from 4,000 patients.
  • Hospital stays for liver transplant patients decreased from 12 to 10 days and post-transplant delirium rates dropped from 26% to 9% with a structured recovery program.

Frequently asked questions

Does Dr. Samstein study liver cancer?
Yes, Dr. Samstein focuses on liver cancer, especially regarding treatments and outcomes for patients undergoing liver transplants.
What treatments has Dr. Samstein researched?
He has researched various treatments including living donor and deceased donor liver transplantation, and techniques to minimize complications in liver surgeries.
Is Dr. Samstein's work relevant for patients needing liver transplants?
Absolutely, his work directly addresses methods to improve survival and reduce complications for liver transplant patients.
What innovative techniques does Dr. Samstein advocate for?
Dr. Samstein advocates for minimally invasive surgery techniques, which lead to shorter recovery times and fewer complications after liver surgery.
What is the EAGLE-LDLT model developed by Dr. Samstein?
It is a predictive tool designed to assess the risk of early graft failure in patients undergoing living donor liver transplantation.

Publications in plain English

Early graft failure after adult living donor liver transplantation: A multicenter risk analysis and development of the early allograft failure in living donor liver transplantation (EAGLE-LDLT) model.

2026

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Li Z, Centonze L, Raptis D, Marquez KAH, Rammohan A +37 more

Plain English
This study developed a new scoring tool to predict which patients undergoing living donor liver transplantation are at the highest risk of losing their graft within 90 days. Using data from nearly 4,000 patients across 18 centers, the EAGLE-LDLT model—based on liver enzyme and clotting values in the first week after surgery—outperformed existing models and correctly identified 40% of high-risk patients. Surgeons can use this tool after transplant to flag patients who need closer monitoring or earlier intervention.

PubMed

Deceased Donor Liver Transplantation and Postoperative Survival in Patients with Unresectable Colorectal Liver Metastases: A Retrospective Multicenter Study.

2026

Journal of the American College of Surgeons

Hill AL, Cullinan DR, Ahmed O, Wesson R, Samstein B +6 more

Plain English
Researchers studied whether liver transplantation using deceased donors is a viable treatment for patients with colorectal cancer that has spread to the liver and cannot be surgically removed. Among 35 patients who received transplants, two-year overall survival reached nearly 85%, and prior use of a hepatic artery pump did not affect outcomes. This confirms that deceased donor liver transplant is a legitimate option for selected colorectal liver metastasis patients, opening the door to centers without access to living donors.

PubMed

Spectrum of Findings Seen in Patients WithCholangiocarcinoma.

2025

International journal of surgical pathology

Kierans AS, Lutfi A, Afghan MK, Khan S, Javaid S +7 more

Plain English
Researchers described 12 patients with a rare subtype of bile duct cancer driven by mutations in the IDH1 or IDH2 genes. These patients were predominantly older women, often had additional co-mutations, and some experienced long-lasting responses to targeted treatments. The report highlights that molecular testing is essential for these patients because specific mutations have both prognostic and treatment implications, with approved targeted drugs now available.

PubMed

Complete transition from laparoscopic to robotic liver surgery achieves superior outcomes in difficult hepatectomies: a seven-year retrospective study.

2025

Surgical endoscopy

Haugen C, Noriega M, Andy C, Waite C, Carpenter D +3 more

Plain English
Surgeons at one institution compared outcomes of open, laparoscopic, and robotic liver removal over seven years as their practice shifted almost entirely to robotic surgery. Robotic cases had 87% lower odds of needing conversion to open surgery compared to laparoscopic, shorter hospital stays, and fewer complications, even for complex cases. The results support a full transition to robotic liver surgery at experienced centers as the standard approach.

PubMed

Validation of a Pretransplant Risk Prediction Model for Early Allograft Dysfunction After Living-donor Liver Transplantation.

2025

Transplantation

Li Z, Raptis D, Rammohan A, Gunasekaran V, Hong S +39 more

Plain English
This study created a pretransplant prediction model to estimate the risk of early graft dysfunction after living donor liver transplantation, using only information available before surgery. Three factors predicted poor graft function: higher disease severity score, being hospitalized at the time of transplant, and receiving a smaller graft. The model can help surgeons better match donors to recipients before the operation to reduce complications.

PubMed

Liver Transplant Fast-Track With an Emphasis on Reduced Delirium: A Multidisciplinary Approach to Reducing Length of Stay.

2025

Clinical transplantation

Salerno DM, Genovese M, Jesudian A, Roman E, Khan M +2 more

Plain English
A hospital implemented a structured fast-track recovery program for liver transplant patients that included lower steroid doses, earlier removal of tubes and drains, and coordinated physical therapy and nutrition care. Hospital stays dropped from 12 to 10 days and the rate of post-transplant delirium fell from 26% to 9%, with no increase in rejection or readmissions. The findings show that aggressive recovery protocols are safe in high-acuity liver transplant patients and meaningfully reduce complications.

PubMed

Living Donor Liver Transplantation for Hepatocellular Carcinoma Within and Outside Traditional Selection Criteria: A Multicentric North American Experience.

2024

Annals of surgery

Ivanics T, Claasen MPAW, Samstein B, Emond JC, Fox AN +23 more

Plain English
This 12-center North American study followed 360 patients who received a living donor liver transplant for liver cancer, including many whose tumors exceeded the standard size and number limits (Milan criteria). Ten-year survival exceeded 60% even for patients outside the criteria, and a newer scoring tool called the NYCA score correctly identified most of these "out-of-criteria" patients as low or acceptable risk. Living donor transplant offers good long-term outcomes for a broader group of liver cancer patients than current criteria allow.

PubMed

Pure laparoscopic donor hepatectomy: A nearly finished product.

2024

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Samstein B, Cherqui D

PubMed

Biliary complications after adult-to-adult living-donor liver transplantation: An international multicenter study of 3633 cases.

2024

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Li Z, Rammohan A, Gunasekaran V, Hong S, Chih-Yi Chen I +36 more

Plain English
This large international study of 3,633 living donor liver transplant patients identified risk factors for the two most common surgical complications: bile leaks and narrowing of the bile duct connection. Multiple bile duct connections, a history of prior abdominal surgery, and blood type incompatibility were among the key risk factors, and both complications significantly shortened graft survival. Careful donor selection and surgical planning are critical to reducing these complications.

PubMed

No Improvement in Intention-to-treat Survival and Increasing Liver Nonutilization Rate During the MELD Era.

2024

Transplantation

Matsumoto R, Verna EC, Rosenblatt R, Emond JC, Brown RS +4 more

Plain English
Researchers analyzed two decades of national liver transplant data and found that while survival after transplant has steadily improved, survival from the time of waitlist listing has not. Over the same period, the rate of donated livers going unused rose significantly, as did the rate of patients dropping off the waitlist before receiving a transplant. This suggests that gains in post-transplant care are being offset by more patients dying while waiting, partly because usable organs are being declined.

PubMed

Minimally invasive tools are necessary for the modern practice of liver surgery.

2024

Journal of minimal access surgery

Yu YD, Halazun KJ, Chandwani R, Samstein B

Plain English
A single surgical center reviewed 260 patients who underwent liver removal and compared outcomes between those who had open versus minimally invasive surgery, with minimally invasive used as the preferred first approach for all patients. The minimally invasive group had shorter operative times, less blood loss, shorter hospital stays, and fewer major complications, with no difference in cancer clearance margins. The study supports making minimally invasive liver surgery the default approach rather than reserving it for select cases.

PubMed

Durvalumab-Induced Immune Thrombocytopenia in Patients with Advanced Cholangiocarcinoma Undergoing Yttrium-90 Radioembolization.

2024

Case reports in oncology

Afghan MK, Lutfi A, Qadri F, Khan S, Javaid S +5 more

Plain English
Two patients with advanced bile duct cancer developed a dangerous drop in platelets shortly after receiving a liver-targeted radiation therapy called yttrium-90 while also on durvalumab immunotherapy. All other causes were ruled out, and both patients required steroids and immune-modulating treatments to recover; one had a recurrent episode requiring additional therapy. This case report alerts clinicians to watch platelet counts closely when combining durvalumab with yttrium-90 radiation.

PubMed

Black patients and women have reduced access to liver transplantation for alcohol-associated liver disease.

2023

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Kaplan A, Wahid N, Fortune BE, Verna E, Halazun K +3 more

Plain English
Using national mortality and transplant listing data from 2014 to 2018, researchers found that patients with alcohol-related liver disease have far lower rates of liver transplant listing relative to deaths than patients with other liver diseases—and within that group, Black patients and women face the greatest disadvantage. Black patients with alcohol-related liver disease were listed at half the rate of White patients. These findings call for targeted interventions to address compounded disparities in transplant access.

PubMed

Practice patterns of the medical evaluation of living liver donors in the United States.

2023

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Jackson WE, Kaplan A, Saben JL, Kriss MS, Cisek J +5 more

Plain English
Researchers surveyed 53 liver transplant programs in the U.S. to understand how they evaluate living liver donors. They found that, on average, about 33% of potential donors were accepted, with most centers agreeing on age limits and excluding donors with obesity. This study highlights differing practices across centers, emphasizing the need for clearer guidelines to ensure safe evaluations of living donors.

PubMed

Safety and Efficacy of Robotic vs Open Liver Resection for Hepatocellular Carcinoma.

2023

JAMA surgery

Di Benedetto F, Magistri P, Di Sandro S, Sposito C, Oberkofler C +13 more

Plain English
Five high-volume centers compared robotic liver removal to traditional open surgery for liver cancer in 398 patients. Robotic patients had shorter hospital stays, fewer ICU admissions, and lower rates of post-operative liver failure, while cancer recurrence rates were equivalent. This is the largest Western study confirming that robotic liver resection for liver cancer is safe, reproducible, and oncologically effective.

PubMed

CAQ Corner: Evaluation and management of the living donor recipient.

2023

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Lee-Riddle GS, Samstein B

PubMed

Vibration Controlled Transient Elastography to Evaluate Steatosis in Candidate Living Donors for Liver Transplantation.

2023

Transplantation

Palte E, Duong JK, Remotti H, Burt J, Makkar J +5 more

Plain English
Researchers tested whether a painless ultrasound-based technique called vibration controlled transient elastography could reliably screen potential living donors for liver fat without requiring a biopsy. Among 79 donor candidates, the tool showed a meaningful correlation with MRI fat measurements and liver biopsy results, with acceptable sensitivity and specificity at defined score cutoffs. Integrating this screening step could reduce the number of invasive biopsies needed during donor evaluation.

PubMed

Advances and innovations in living donor liver transplant techniques, matching and surgical training: Meeting report from the living donor liver transplant consensus conference.

2023

Clinical transplantation

Sturdevant M, Ganesh S, Samstein B, Verna EC, Rodriguez-Davalos M +17 more

Plain English
Researchers looked into the challenges and potential improvements in living donor liver transplants (LDLT) during a conference in October 2021. They found that issues like donor age, size, and blood type mismatches, along with a lack of awareness about the benefits of LDLT and a shortage of skilled surgeons, hinder its growth in the U.S. They recommend creating a national registry for better matching and improving surgical training to ensure more successful transplants, which could greatly increase the availability and effectiveness of these procedures.

PubMed

Another Tool in the Quest for the Perfect Living Liver Donor Operation.

2023

Transplantation

Samstein B

PubMed

National survey of second opinions for hospitalized patients in need of liver transplantation.

2023

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Kaplan A, Lee-Riddle GS, Nobel Y, Dove L, Shenoy A +4 more

Plain English
A national survey of 60 U.S. liver transplant programs examined how often and under what circumstances centers refer declined patients for a second opinion at another center. While all centers receive second-opinion referrals, only 25% frequently facilitate them for their own declined patients, and practices vary widely with no standardized process. Standardizing second-opinion pathways could improve equity for patients denied transplant listing.

PubMed

Novel Benchmark for Adult-to-Adult Living-donor Liver Transplantation: Integrating Eastern and Western Experiences.

2023

Annals of surgery

Li Z, Rammohan A, Gunasekaran V, Hong S, Chen IC +36 more

Plain English
An international team of 15 high-volume liver transplant centers established reference benchmarks for living donor liver transplantation outcomes, similar to quality standards that exist for other surgical procedures. Living donor transplants matched or outperformed deceased donor transplants on most measures like graft loss and need for retransplantation, though bile leaks and hepatic artery clots remained higher. These benchmarks give transplant programs a concrete target for quality improvement and international comparison.

PubMed

Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer.

2023

Oncogene

Kasi PM, Hidalgo M, Jafari MD, Yeo H, Lowenfeld L +18 more

Plain English
Two patients with locally advanced colon and rectal cancer that typically does not respond to immunotherapy received a combination of two immune checkpoint drugs before surgery. Both had dramatic tumor responses with a distinctive inside-out pattern of immune cell attack not previously described, and molecular analysis revealed the drugs activated both innate and adaptive immune pathways. These cases suggest that this drug combination may overcome immunotherapy resistance in certain colorectal cancers and should be tested in clinical trials.

PubMed

The use of nondirected donor organs in living donor liver transplantation: Perspectives and guidance.

2022

Hepatology (Baltimore, Md.)

Fox AN, Liapakis A, Batra R, Bittermann T, Emamaullee J +13 more

Plain English
This consensus guidance article reviews available evidence and draws on kidney donation experience to provide practical recommendations for evaluating anonymous living liver donors—people who donate to strangers rather than a specific recipient. The authors address donor selection criteria, allocation of nondirected grafts, and ethical considerations to ensure safe expansion of this practice. The guidance aims to standardize an emerging practice that could meaningfully increase the supply of living donor livers.

PubMed

Practices and Perceptions of Living Donor Liver Transplantation, Nondirected Donation, and Liver Paired Exchange: A National Survey.

2022

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Kaplan A, Rosenblatt R, Jackson W, Samstein B, Brown RS

Plain English
A national survey of 99 liver transplant programs explored current use of nondirected living liver donation (where a stranger donates to an unknown recipient) and liver paired exchange (where incompatible donor-recipient pairs swap). Most programs accepting living donors allowed nondirected donation, but only 12% performed paired exchange, though 78% said they would participate if logistical barriers were resolved. Understanding these gaps can guide policy efforts to make more flexible forms of living donation routine.

PubMed

Assessing motivations for non-living and living organ donation among individuals with and without a history of blood donation.

2022

Transfusion medicine (Oxford, England)

France CR, France JL, Ysidron DW, Samstein B

Plain English
An online survey examined whether people who had previously donated blood were more likely to be registered as organ donors or to donate a living organ, and whether their motivations differed. Blood donation history did not predict organ donor registration or interest in living donation. The results suggest that different outreach strategies are needed for blood donation and organ donation recruitment.

PubMed

Sociodemographic characteristics of living liver donors: Few changes over 20 years.

2022

Clinical transplantation

Kaplan A, Wahid N, Lee J, Fortune BE, Halazun KJ +4 more

Plain English
Researchers analyzed 20 years of national data on living liver donors and found that the demographic profile has changed very little: donors remain predominantly young, White, employed, and college-educated, with a recent rise in female donors. The narrow socioeconomic and racial profile of donors likely reflects structural barriers to donation rather than medical exclusions. Addressing financial and social obstacles to donation is essential to diversify the donor pool.

PubMed

Deceased donor liver transplantation in patients on direct oral anticoagulants at the time of transplant surgery: A case series.

2022

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Salerno DM, Lee-Riddle GS, Brar S, Samstein B, Brown RS +1 more

PubMed

Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma.

2022

JAMA surgery

Tabrizian P, Holzner ML, Mehta N, Halazun K, Agopian VG +12 more

Plain English
A 10-year multicenter study of 2,645 liver transplant patients with liver cancer found that patients whose tumors were successfully shrunk to within transplant criteria before surgery had excellent long-term outcomes, similar to patients who always met criteria. Ten-year survival for the downstaged group was 52%, and patients whose cancer recurred after transplant lived longer if they were able to have surgical treatment of the recurrence. These data strongly support national policies allowing downstaged patients to receive liver transplants.

PubMed

Ex Vivo Liver Resection and Autotransplantation: Should It be Used More Frequently?

2022

Annals of surgery

Weiner J, Hemming A, Levi D, Beduschi T, Matsumoto R +7 more

Plain English
Surgeons at five institutions reviewed their collective experience with a technically demanding procedure called ex vivo liver resection, in which the liver is removed from the body, the tumor is cut out on a back table, and the liver is then reimplanted. Among 35 patients with otherwise unresectable tumors, five-year survival reached 28%, and the required surgical skills overlap with those already used in partial liver transplant. The findings argue that more liver transplant centers should consider adding this technique to treat patients with no other surgical options.

PubMed

The Delicate Balance Between Donors and Recipients.

2021

Transplantation

Samstein B

PubMed

Expert Consensus Guidelines on Minimally Invasive Donor Hepatectomy for Living Donor Liver Transplantation From Innovation to Implementation: A Joint Initiative From the International Laparoscopic Liver Society (ILLS) and the Asian-Pacific Hepato-Pancreato-Biliary Association (A-PHPBA).

2021

Annals of surgery

Cherqui D, Ciria R, Kwon CHD, Kim KH, Broering D +20 more

Plain English
An international panel of experts in minimally invasive donor liver surgery developed 44 clinical practice guidelines to help transplant centers safely adopt laparoscopic and robotic techniques for living donor hepatectomy. The guidelines address patient selection, surgical technique, training, and safety monitoring and reached over 90% consensus among experts. This framework gives centers clear standards to follow as minimally invasive donor surgery becomes more widely available.

PubMed

SARS-CoV-2 infection increases tacrolimus concentrations in solid-organ transplant recipients.

2021

Clinical transplantation

Salerno DM, Kovac D, Corbo H, Jennings DL, Lee J +14 more

PubMed

Black Patients Have Unequal Access to Listing for Liver Transplantation in the United States.

2021

Hepatology (Baltimore, Md.)

Rosenblatt R, Wahid N, Halazun KJ, Kaplan A, Jesudian A +8 more

Plain English
Using national death and transplant registry data from 2014 to 2018, researchers found that Black patients with end-stage liver disease are placed on the transplant waiting list at a significantly lower rate relative to deaths than White patients, despite having similar transplant success rates once listed. This gap existed in every state analyzed and persisted after adjusting for other factors. The findings reveal a systemic barrier to transplant access for Black patients before they ever reach the waitlist.

PubMed

Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma.

2021

JAMA surgery

Halazun KJ, Rosenblatt RE, Mehta N, Lai Q, Hajifathalian K +24 more

Plain English
Researchers validated a new scoring tool for selecting liver transplant candidates with liver cancer by testing it on data from 2,236 patients across eight international centers. The New York/California (NYCA) score—which incorporates how a patient's AFP tumor marker changes over time—outperformed older size-based criteria and correctly reclassified most patients previously excluded under those criteria into acceptable-risk categories. This score offers transplant programs a more accurate, biology-based way to decide who benefits from liver transplantation.

PubMed

Rare Histological Variants of Liver Cancer and Their Management: A Single-Institution Experience.

2021

Case reports in hepatology

Swed B, Gandarilla O, Chiu K, Halazun KH, Samstein B +2 more

Plain English
Five patients with rare subtypes of primary liver cancer—including combined liver-bile duct cancer, virus-associated carcinoma, and unusual cell-type variants—were described along with the treatments used when their cancers returned after surgery. Each case illustrates how the specific tumor subtype influenced treatment choices including chemotherapy, targeted therapy, and immunotherapy. Recognizing these rare variants matters because standard liver cancer treatment guidelines may not apply.

PubMed

Can Living Donor Liver Transplantation in the United States Reach Its Potential?

2021

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Kaplan A, Rosenblatt R, Samstein B, Brown RS

Plain English
This review outlines the innovations and policy changes most likely to expand living donor liver transplantation in the United States, where it remains a small fraction of all transplants. Promising developments include nondirected donation, paired exchange, ABO-incompatible transplants, laparoscopic and robotic donor surgery, and financial support for donors. The review provides a roadmap for transplant programs and policymakers to grow living donation safely and equitably.

PubMed

COVID-19 in solid organ transplant recipients: Initial report from the US epicenter.

2020

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Pereira MR, Mohan S, Cohen DJ, Husain SA, Dube GK +21 more

Plain English
Among the first 90 solid organ transplant patients infected with COVID-19 in New York City, 30% had severe disease requiring ICU admission and 18% died—substantially higher than in the general population at the time. Most patients received hydroxychloroquine-based regimens, and immunosuppression was often reduced. This early report established the clinical baseline for transplant recipients with COVID-19 and shaped initial management approaches.

PubMed

Hidden Carcinoma: Pitfalls in the Diagnosis of Lymphoepithelioma-Like Cholangiocarcinoma.

2020

International journal of surgical pathology

Mostyka M, Birch MM, Samstein B, Pittman ME

Plain English
Two cases are described in which a rare type of bile duct cancer closely mimicking a lymphoma led to missed or delayed diagnoses on initial tissue sampling. The tumor's dense immune cell infiltrate hid the underlying cancer on frozen section and biopsy, and the report offers specific microscopic and staining features to help pathologists recognize it. Awareness of this diagnostic pitfall can prevent misdiagnosis and treatment delays in this unusual cancer.

PubMed

Minimally invasive donor hepatectomy, systemic review.

2020

International journal of surgery (London, England)

Cho HD, Samstein B, Chaundry S, Kim KH

Plain English
This review summarizes the global experience with minimally invasive surgical techniques for removing part of a living donor's liver for transplantation, from early laparoscopic left lateral donor surgery to fully laparoscopic half-liver removal. The evidence supports laparoscopic left lateral liver removal as a standard of care for pediatric donation, and a growing number of experienced centers have extended the approach to larger donor operations. Expanding minimally invasive donor hepatectomy reduces recovery time and surgical burden for living donors.

PubMed

Trinational Study Exploring the Early Impact of the COVID-19 Pandemic on Organ Donation and Liver Transplantation at National and Unit Levels.

2020

Transplantation

Reddy MS, Hakeem AR, Klair T, Marcon F, Mathur A +8 more

Plain English
Researchers compared weekly organ donation and liver transplant activity during the first three months of the COVID-19 pandemic to the same period the prior year in the United States, United Kingdom, and India. Transplant volumes fell sharply in all three countries, dropping over 80% at peak in the UK and India, with early signs of recovery by the end of the study period. The study documents the pandemic's severe disruption to life-saving transplant services and the policy adaptations used to maintain some activity.

PubMed

Ex Vivo Resection and Autotransplantation for Conventionally Unresectable Tumors - An 11-year Single Center Experience.

2020

Annals of surgery

Kato T, Hwang R, Liou P, Weiner J, Griesemer A +6 more

Plain English
A single center reported 11-year outcomes for 46 patients who underwent ex vivo surgery—removing abdominal organs, resecting the tumor off the operating table, and reimplanting the organs—for tumors that could not be removed by any other means. Overall five-year survival was 52%, with 91% of patients achieving complete tumor removal and an in-hospital mortality rate of about 4%. The results support selective use of this procedure at centers with transplant expertise for patients who have no other surgical option.

PubMed

Living Donor Liver Transplant: Send in the Robots.

2020

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Halazun KJ, Samstein B

PubMed

Portal Cavernoma Cholangiopathy: Histologic Features and Differential Diagnosis.

2019

American journal of clinical pathology

Pittman ME, Kierans AS, Rao D, Yantiss RK, Samstein B +1 more

Plain English
Three liver specimens from patients with a rare bile duct condition caused by portal vein blockage—portal cavernoma cholangiopathy—were analyzed to describe its microscopic features, which have not been well characterized. Key findings included abnormal or absent portal veins within the liver and signs of bile duct obstruction that can closely resemble cholangiocarcinoma or cirrhosis. Recognizing these histologic patterns can prevent misdiagnosis, particularly when a biopsy is taken from a patient with known portal vein thrombosis.

PubMed

Agree on much, except it is time for change.

2019

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Samstein B, McElroy LM

Plain English
This commentary argues that the long-standing imbalance between the supply and demand for donor organs cannot be solved by redistribution policy changes alone, and that improving organ procurement organization performance is essential. Meaningful reform requires transparent performance metrics, partnership between transplant centers and procurement organizations, and patient-centered data. Geographic redistribution proposals risk oversimplifying a problem that requires systemic, collaborative solutions.

PubMed

Whose Liver Is It Anyway? Two Centers Participating in One Living Donor Transplantation.

2019

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Yu YD, Hwang R, Halazun KJ, Griesemer A, Kato T +2 more

PubMed

Liver paired exchange: Can the liver emulate the kidney?

2018

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Mishra A, Lo A, Lee GS, Samstein B, Yoo PS +5 more

Plain English
This article examines whether liver transplant programs in the United States could establish a paired exchange program modeled on the successful kidney paired exchange system, where incompatible donor-recipient pairs swap to enable compatible transplants. The authors analyze the specific logistical, medical, and ethical challenges unique to liver donation that would need to be resolved. A liver paired exchange program could meaningfully expand living donor liver transplantation for patients who currently have no compatible donor.

PubMed

A liver for a kidney: Ethics of trans-organ paired exchange.

2018

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Samstein B, de Melo-Martin I, Kapur S, Ratner L, Emond J

Plain English
This ethics article explores the concept of trans-organ paired exchange, in which a person willing to donate a kidney could instead donate part of their liver to allow a liver recipient's willing donor to donate a kidney—crossing organ type boundaries to enable more transplants. The authors examine the ethical challenges including mismatched surgical risks between donor operations, the validity of informed consent when donation is indirect, and potential effects on deceased donor rates. The piece argues these challenges are addressable and that trans-organ exchange deserves serious consideration to expand access to both liver and kidney transplantation.

PubMed

Is it Time to Abandon the Milan Criteria?: Results of a Bicoastal US Collaboration to Redefine Hepatocellular Carcinoma Liver Transplantation Selection Policies.

2018

Annals of surgery

Halazun KJ, Tabrizian P, Najjar M, Florman S, Schwartz M +6 more

Plain English
Researchers developed the New York/California (NYCA) score, a new tool to select liver transplant candidates with liver cancer that goes beyond tumor size and count to include how the AFP blood marker changes over time before transplant. The score outperformed the standard Milan Criteria in predicting cancer-free survival and would allow 85% of patients currently excluded under Milan Criteria to safely receive a transplant. This model gives U.S. transplant programs a practical, evidence-based tool to expand liver cancer transplant eligibility.

PubMed

Pure Laparoscopic Donor Hepatectomies: Ready for Widespread Adoption?

2018

Annals of surgery

Samstein B, Griesemer A, Halazun K, Kato T, Guarrera JV +2 more

Plain English
Surgeons reported their experience performing 51 fully laparoscopic liver removals for living donors, the first such large series from a US center, comparing outcomes to open donation. Laparoscopic donors had longer operations but similar complication rates, and graft survival in recipients was 94% at one year. The results support cautious expansion of fully laparoscopic living donor hepatectomy at centers with sufficient expertise.

PubMed

Durable Clinical and Immunologic Advantage of Living Donor Liver Transplantation in Children.

2018

Transplantation

Przybyszewski EM, Verna EC, Lobritto SJ, Martinez M, Vittorio JM +5 more

Plain English
Children who receive livers from living donors—usually parents—have better long-term outcomes than those receiving deceased-donor organs, but living donor transplants remain rare in the U.S. This study found that living-donor recipients also showed immunological advantages, with lower rejection rates likely tied to the partial genetic match with a parent donor. The data make a strong case for expanding living donor programs for children.

PubMed

Frequent Co-Authors

Jean C Emond Robert S Brown Karim J Halazun Russell Rosenblatt Abhishek Mathur Gonzalo Sapisochin Tomoaki Kato Alyson Kaplan Kim M Olthoff Timucin Taner

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.